226 related articles for article (PubMed ID: 10970691)
1. MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells.
Chen GK; Durán GE; Mangili A; Beketic-Oreskovic L; Sikic BI
Br J Cancer; 2000 Oct; 83(7):892-8. PubMed ID: 10970691
[TBL] [Abstract][Full Text] [Related]
2. Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol).
Dumontet C; Duran GE; Steger KA; Beketic-Oreskovic L; Sikic BI
Cancer Res; 1996 Mar; 56(5):1091-7. PubMed ID: 8640766
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of multidrug resistance related to activation of the mdr1 gene in human sarcoma mutants derived by single-step doxorubicin selection.
Chen KG; Jaffrézou JP; Fleming WH; Durán GE; Sikic BI
Cancer Res; 1994 Sep; 54(18):4980-7. PubMed ID: 7915196
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of taxotere-related drug resistance in pancreatic carcinoma.
Liu B; Staren ED; Iwamura T; Appert HE; Howard JM
J Surg Res; 2001 Aug; 99(2):179-86. PubMed ID: 11469885
[TBL] [Abstract][Full Text] [Related]
5. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI
J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
[TBL] [Abstract][Full Text] [Related]
6. Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts.
Kolfschoten GM; Hulscher TM; Pinedo HM; Boven E
Br J Cancer; 2000 Oct; 83(7):921-7. PubMed ID: 10970695
[TBL] [Abstract][Full Text] [Related]
7. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.
Li G; Chen X; Wang Q; Xu Z; Zhang W; Ye L
J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):173-5. PubMed ID: 17497289
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
9. Stable suppression of MDR-1 gene using siRNA expression vector to reverse drug resistance in a human uterine sarcoma cell line.
Hua J; Mutch DG; Herzog TJ
Gynecol Oncol; 2005 Jul; 98(1):31-8. PubMed ID: 15921732
[TBL] [Abstract][Full Text] [Related]
10. Mutation rates and mechanisms of resistance to etoposide determined from fluctuation analysis.
Jaffrézou JP; Chen KG; Durán GE; Kühl JS; Sikic BI
J Natl Cancer Inst; 1994 Aug; 86(15):1152-8. PubMed ID: 8028036
[TBL] [Abstract][Full Text] [Related]
11. Anticancer drug sensitivity and expression of multidrug resistance markers in early passage human sarcomas.
Hoffmann J; Schmidt-Peter P; Hänsch W; Naundorf H; Bunge A; Becker M; Fichtner I
Clin Cancer Res; 1999 Aug; 5(8):2198-204. PubMed ID: 10473106
[TBL] [Abstract][Full Text] [Related]
12. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
[TBL] [Abstract][Full Text] [Related]
13. Pediatric glioblastoma cell line shows different patterns of expression of transmembrane ABC transporters after in vitro exposure to vinblastine.
Valera ET; de Freitas Cortez MA; de Paula Queiroz RG; de Oliveira FM; Brassesco MS; Jabado N; Faury D; Bobola MS; Machado HR; Scrideli CA; Tone LG
Childs Nerv Syst; 2009 Jan; 25(1):39-45. PubMed ID: 18946672
[TBL] [Abstract][Full Text] [Related]
14. ABCB1, ABCC1, and LRP gene expressions are altered by LDL, HDL, and serum deprivation in a human doxorubicin-resistant uterine sarcoma cell line.
Celestino AT; Levy D; Maria Ruiz JL; Bydlowski SP
Biochem Biophys Res Commun; 2015 Feb; 457(4):664-8. PubMed ID: 25603048
[TBL] [Abstract][Full Text] [Related]
15. Co-transfection of MDR1 and MRP antisense RNAs abolishes the drug resistance in multidrug-resistant human lung cancer cells.
Gao Z; Gao Z; Fields JZ; Boman BM
Anticancer Res; 1998; 18(4C):3073-6. PubMed ID: 9713512
[TBL] [Abstract][Full Text] [Related]
16. Expression profiles of vault components MVP, TEP1 and vPARP and their correlation to other multidrug resistance proteins in ovarian cancer.
Szaflarski W; Sujka-Kordowska P; Pula B; Jaszczyńska-Nowinka K; Andrzejewska M; Zawierucha P; Dziegiel P; Nowicki M; Ivanov P; Zabel M
Int J Oncol; 2013 Aug; 43(2):513-20. PubMed ID: 23739867
[TBL] [Abstract][Full Text] [Related]
17. Preferential expression of a mutant allele of the amplified MDR1 (ABCB1) gene in drug-resistant variants of a human sarcoma.
Chen KG; Lacayo NJ; Durán GE; Wang Y; Bangs CD; Rea S; Kovacs M; Cherry AM; Brown JM; Sikic BI
Genes Chromosomes Cancer; 2002 Aug; 34(4):372-83. PubMed ID: 12112526
[TBL] [Abstract][Full Text] [Related]
18. The association of increased lung resistance protein expression with acquired etoposide resistance in human H460 lung cancer cell lines.
Lee E; Lim SJ
Arch Pharm Res; 2006 Nov; 29(11):1018-23. PubMed ID: 17146971
[TBL] [Abstract][Full Text] [Related]
19. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.
Kourti M; Vavatsi N; Gombakis N; Sidi V; Tzimagiorgis G; Papageorgiou T; Koliouskas D; Athanassiadou F
Int J Hematol; 2007 Aug; 86(2):166-73. PubMed ID: 17875533
[TBL] [Abstract][Full Text] [Related]
20. Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines.
Laurençot CM; Scheffer GL; Scheper RJ; Shoemaker RH
Int J Cancer; 1997 Sep; 72(6):1021-6. PubMed ID: 9378536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
